GENEVA, July 18 -- THE REGENTS OF THE UNIVERSITY OF MICHIGAN filed a patent application (US2026/010788) for “STING AGONISTS, FORMULATIONS, AND USES THEREOF”. With publication no. WO/2026/151996, here ... Read More
GENEVA, July 18 -- ORIC PHARMACEUTICALS, INC. filed a patent application (US2026/010789) for “TREATMENT OF PROSTATE CANCER”. With publication no. WO/2026/151997, here are the other details related to ... Read More
GENEVA, July 18 -- REGENX SCIENCE, INC. filed a patent application (US2026/010790) for “CONDITIONED WATER CONTAINING AMPHIBIAN BIOACTIVE MOLECULES AND USES THEREOF”. With publication no. WO/2026/15199... Read More
GENEVA, July 18 -- ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA filed a patent application (US2026/010782) for “METHODS AND SYSTEMS FOR INCREMENTAL RECONSTRUCTION OF MICROSERVICES-B... Read More
GENEVA, July 18 -- USADMT, INC. filed a patent application (US2026/010783) for “AUTOMATED COMPLIANCE MONITORING”. With publication no. WO/2026/151992, here are the other details related to the patent ... Read More
GENEVA, July 18 -- ERASCA, INC. filed a patent application (US2026/010785) for “METHOD OF TREATMENT OF DRUG-INDUCED SKIN TOXICITY”. With publication no. WO/2026/151993, here are the other details rela... Read More
GENEVA, July 18 -- LOCKNCLIMB LLC filed a patent application (US2026/010777) for “WINDSHIELD INSTALLATION LADDER”. With publication no. WO/2026/151986, here are the other details related to the patent... Read More
GENEVA, July 18 -- CORAVIE MEDICAL, INC. filed a patent application (US2026/010779) for “SYSTEMS AND METHODS FOR ENERGY-EFFICIENT PULSING IN ULTRASOUND-BASED BLOOD PRESSURE SENSOR IMPLANTS”. With publ... Read More
GENEVA, July 18 -- BIOCRYST PHARMACEUTICALS, INC. filed a patent application (US2026/010780) for “USE OF AVORALSTAT IN THE TREATMENT OF DIABETIC MACULAR EDEMA AND RELATED OCULAR DISEASES”. With public... Read More
GENEVA, July 18 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/010773) for “METHODS OF TREATING FOOD ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST AND A BCMA TARGETING AGENT”. Wi... Read More